Business Context and Reporting Period
This Form 8-K filing by IRADIMED CORP (IRMD) reports on the results of the Annual Meeting of Stockholders held on June 12, 2020. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting outcomes. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent Form 10-K or 10-Q for financial performance details.
Material Changes and Voting Results
The filing details the outcomes of five proposals voted upon by stockholders:
- Director Elections: Stockholders elected Roger Susi, Monty Allen, Anthony Vuoto, and James Hawkins to the Board of Directors. All candidates received majority support, with "Votes For" ranging from approximately 7.9 million to 8.9 million shares.
- Auditor Ratification: Stockholders ratified the selection of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020. The proposal passed with 11,097,213 votes for and only 3,878 votes against.
- Equity Incentive Plan: Stockholders approved the Amended and Restated 2014 Equity Incentive Plan, increasing the number of shares available for grant from 1,000,000 to 2,000,000. The proposal received 7,422,082 votes for and 1,925,917 votes against.
- Executive Compensation (Say-on-Pay): Stockholders approved an advisory resolution on the compensation of named executive officers with 7,757,344 votes for and 1,547,459 votes against.
- Frequency of Say-on-Pay Votes: Stockholders voted on an advisory basis to hold future advisory votes on executive compensation every 1 year, with 9,256,673 votes cast for the one-year frequency.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, specific risks, contingencies, or unusual items. The document is strictly limited to reporting the vote tallies from the annual meeting.
Key Facts for Investor Verification
- Verify the impact of the increased share pool (2,000,000 shares) under the amended Equity Incentive Plan on potential future dilution.
- Confirm the tenure of the newly elected directors (Roger Susi, Monty Allen, Anthony Vuoto, James Hawkins) until the next annual meeting.
- Note the strong shareholder support for the one-year frequency of executive compensation advisory votes.
- Review the company's separate financial filings (10-K/10-Q) for actual financial performance, as this 8-K contains no financial metrics.